14 Contrarian Opinions on the State of our Industry.
Orthopedics has shifted—you feel it in your bones. Don’t hate me. I talk with alot of people, and just share […]
Orthopedics has shifted—you feel it in your bones. Don’t hate me. I talk with alot of people, and just share […]
Why Read? Ortho sales is hyper-competitive. Reps must juggle high-stakes interactions in operating rooms and hospitals while grappling with scattered
It’s earnings season and we had two crazy stock moves after Q3 2025 earnings calls last week. Globus accelerated and
Which of these resonates with you the most? Vote by commenting your favorite number below—I’d love to hear why it
In the world of orthopedics, few stories capture the highs and lows like Exactech’s— from groundbreaking innovation to crippling recalls
Tiger’s Take: Acumed has made a strategic purchase of certain assets developed by TECHFIT Digital Surgery, particularly the DISRP online
The current funding environment is notoriously challenging, particularly in the Ortho space. On a discussion with the BoneChat community, finance
The Big Orthos continue to grow with their access advantages, new products from M&A, and organized sales force. The pattern
“The hardest startup challenge: Building a sales force that converts.” The single hardest challenge for any orthopedic startup isn’t product
I received a call from an orthopedic surgeon: “How do I break into venture capital as a physician?” The answer
In orthopedics, innovation drives competition and talent is the ultimate differentiator, and companies sometimes need to make moves in the
I’m about to offend a few of my orthopedic colleagues, but I have to be honest—this is a real challenge
Why read? This is a comprehensive article of the role of genome mapping in orthopedic medicine, posing the question why
Why read this? Real-time data from inside the body will become a tool that all patients and healthcare providers use
My clinical friends in ortho are going to hate this topic. We are going to talk about an uncomfortable aspect
Venture money has been tight for over three years and counting, so a few ortho businesses are tapping into the
Orthopedics has long grappled with an accuracy conundrum—not in the finesse of individual techniques, but in the elusive quest to
Why Read? You and I both know that printing tissue from our own cells is the future of ortho. It’s
I see big opportunities in non-implant ortho businesses, now more than ever. In this article I am going to make
Tiger’s 5 quick takes: 1/ Ortho Access Wars This move validates my point that innovating in Ortho has gotten harder
Why read this? Learn how a Canadian startup has democratized precision navigation in hip and knee replacements—using a tiny, Wii-inspired
I have been watching ortho startups for 30 years. This simple grid is surprisingly predictive of outcomes. In the grid,
High Level Summary Researchers have unveiled Bone-02, a bioabsorbable adhesive that bonds fractures in 2–3 minutes via injection, potentially transforming
Why Read? As a leader of a nimble ortho company navigating tight margins and fierce competition, this article arms you
Why read this ? Learn how the Implant Identifier app is transforming the frustrating, time-intensive hunt for orthopedic implants in
Sharing this statement from Gardiner Harris, former New York Times correspondent. This quote comes from a talk Gardiner Harris gave
Yes, it’s here. We have all felt this trend over the last few quarters, but now the real macro data
One of the most rewarding yet challenging journeys is building an orthopedic medical device startup from scratch. As a leader,
What just happened? Johnson & Johnson Announces Strategic Agreement with Pacira BioSciences to Expand Early Intervention Offering for Osteoarthritis of
I recently covered Carlsmed’s bold $100M IPO bid, noting how rare orthopedic offerings have been in recent years. Now, Shoulder
In orthopedic surgery, precision reigns supreme—surgeons place implants with sub-millimeter accuracy, yet monitoring recovery often feels like navigating by outdated
Disclaimer: This is not legal advice or financial advice and I do not own any Treace stock. OK, not let’s
Why read? In the spine arena where flashy navigation tools like Brainlab’s new Spine Mixed Reality system dazzle with promises
OrthoSens is an innovative Swiss medtech startup founded in 2021, focused on transforming standard orthopedic implants into “smart” devices capable of
Why read this? To understand how the orthopedic sales rep role has evolved over time. What happened? How did reps
Today, we pause to honor and celebrate the remarkable life of Dr. Chitranjan S. Ranawat—a true pioneer whose vision and
After countless conversations with professionals in orthopedics, I’ve noticed a common theme: many careers stall because people are too far
This article exposes how Group Purchasing Organizations erect invisible barriers that sideline innovative small orthopedic companies, costing patients safer, cheaper
I wrote about Sports Medicine’s big moment is here now. Today, I’m sharing a stealth startup today in the sports
Why read. In this eye-opening piece, a battle-tested ortho medtech leader—who’s championed H-1B hires from India, China, and Malaysia for
I have been working on and thinking about knee OA for decades. FACT: There is a gaping hole in treatment
I wrote about this issue months ago – The shortage of ETO suppliers is stressing orthopedic device companies. Now we
This acquisition story is complicated and changing day-to-day. Let me try to make sense of this saga. Websites – https://integrum.se/
I talk with a ton of ortho people each week. Seems like everyone wants to talk about AI. But through
This week, I’m fired up about Bioretec, a Finnish trailblazer in bioresorbable orthopedic implants that’s redefining fracture fixation by making
Why read This article is worth reading because it spotlights an emerging medtech startup revolutionizing knee injury treatment with a
Ortho has changed. You and I have both been affected by these changes. Some change has made your ortho life
Why Read? Read this if you want to understand hospital value analysis demystifies procurement barriers for small orthopedics device companies.
In an era where venture capital flows like molasses—particularly for fledgling spine startups navigating regulatory hurdles, market saturation, and investor
This article is worth reading because it uncovers the harsh realities and cautionary tales behind failed orthopedic startups, offering invaluable